home / stock / cydy / cydy news


CYDY News and Press, CytoDyn Inc From 06/19/20

Stock Information

Company Name: CytoDyn Inc
Stock Symbol: CYDY
Market: OTC
Website: cytodyn.com

Menu

CYDY CYDY Quote CYDY Short CYDY News CYDY Articles CYDY Message Board
Get CYDY Alerts

News, Short Squeeze, Breakout and More Instantly...

CYDY - ENDRA Life Sciences' NASH Test Device, TAEUS, At Commercialization Inflection Point

ENDRA Life Sciences Inc. (NDRA) recently announced it is moving forward with the commercialization of its Thermo Acoustic Enhanced UltraSound (TAEUS) device in Europe. The TAEUS device is essentially a point of care ((POC)) or field diagnostic hybrid of an ultrasound and MRI that can monitor...

CYDY - "Next Super Stocks" in News: (OTC: NEXCF): Revenues Accelerating with Virtual Meetings - (OTC: CYDY): Clinical progress in COVID-19, HIV & Cancer - (OTC: KULR): Battery Tech for Electric Vehicles and Space Exploration - (OTC: IPNFF) AR Tech for "Spor

NEW YORK, June 17, 2020 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, is highlighting companies which recently presented at its Next Super Stock & Investors Discovery Day livestream conference series that are making news this week. NexTech ...

CYDY - CytoDyn Initiates Phase 2 Clinical Trial With Leronlimab for Treatment of NASH

Preclinical results demonstrated leronlimab effectively inhibited fatty liver development VANCOUVER, Washington, June 11, 2020 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY) , (“CytoDyn” or the “Company"), a late-stage biotechnology company developing leronlimab...

CYDY - CytoDyn Reached Its Enrollment Target for Phase 2 COVID-19 Trial for Mild to Moderate Indication - Primary End Point Announcement Is Next

VANCOUVER, Washington, June 11, 2020 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY) , (“CytoDyn” or the “Company"), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced...

CYDY - Drs. Pourhassan and Kelly of CytoDyn to Hold Conference Call to Provide Updates on COVID-19 Phase 2 and 3 Trials, NASH, BLA for HIV and Manufacturing of Leronlimab in 2020-2021

VANCOUVER, Washington, June 09, 2020 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY) , (“CytoDyn” or the “Company"), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced...

CYDY - CytoDyn Receives BLA Acknowledgment Letter From the FDA

PDUFA date could be set by the FDA on July 10 VANCOUVER, Washington, June 08, 2020 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY) , (“CytoDyn” or the “Company"), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the poten...

CYDY - CytoDyn: COVID-19 Crunch Time

I have recently written a spate of predominately skeptical articles on CytoDyn ( CYDY ), a little OTC stock that was trading for ~$0.50 on 2/22/2019. That was the date of my first article setting out my biggest question at the time, "CytoDyn: What To Do When It's Too Good To Be True?" A ...

CYDY - COVID-19 Therapeutics: The Leading Contenders

The need for medicines that help Covid-19 patients before the disease leaves the viral response phase and enters the host inflammatory phase has never been greater. While there are some positive signals in the prevention area, the most frequent estimates I am reading place a realistic timeli...

CYDY - CytoDyn gives Mulholland permanent CFO job

CytoDyn ( OTCQB:CYDY ) says it promoted its interim chief financial officer to the permanent job. More news on: CytoDyn Inc., Healthcare stocks news, Read more ...

CYDY - CytoDyn to Present at Wall Street Reporter's Livestream Event on June 2, 2020 at 12:30 pm ET / 9:30 am PT

VANCOUVER, Washington, June 01, 2020 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY) , (“CytoDyn” or the “Company"), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced...

Previous 10 Next 10